Back
State Street Financial Sel Sec SPDR ETF Vs. Krystal Biotech, Inc. Industry Stock Comparison
Buy
70
XLF
State Street Financial Sel Sec SPDR ETF
Last Price:
$55.33
Seasonality Move:
0.54%
Buy
77
KRYS
Krystal Biotech, Inc.
Last Price:
$249.58
Seasonality Move:
5.72%
Buy
70
State Street Financial Sel Sec SPDR ETF (XLF)
is a Buy
Is State Street Financial Sel Sec SPDR ETF a Buy, Sell or Hold?
-
The current State Street Financial Sel Sec SPDR ETF [XLF] share price is $55.32. The Score for XLF is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
XLF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
Krystal Biotech, Inc. (KRYS)
is a Buy
Is Krystal Biotech, Inc. a Buy, Sell or Hold?
-
The current Krystal Biotech, Inc. [KRYS] share price is $249.61. The Score for KRYS is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
KRYS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XLF Stock Price Chart
What is State Street Financial Sel Sec SPDR ETF's stock price today?
-
The State Street Financial Sel Sec SPDR ETF share price today is $55.32Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XLF is experiencing buying pressure, which is a positive indicator for future bullish movement.
KRYS Stock Price Chart
What is Krystal Biotech, Inc.'s stock price today?
-
The Krystal Biotech, Inc. share price today is $249.61Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KRYS is experiencing buying pressure, which is a positive indicator for future bullish movement.
XLF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.21 | Buy |
| Relative Strength Index (14 RSI): | 68.4 | Buy |
| Chaikin Money Flow: | 24963392 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.08 - 54.64) | Buy |
| Bollinger Bands (100): | (52.19 - 54.01) | Buy |
KRYS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.29 | Buy |
| Relative Strength Index (14 RSI): | 73.55 | Buy |
| Chaikin Money Flow: | 246382 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (211.56 - 240.16) | Buy |
| Bollinger Bands (100): | (150.53 - 215.13) | Buy |
XLF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.85 | Buy |
| 20-day SMA: | 53.84 | Buy |
| 50-day SMA: | 53.03 | Buy |
| 200-day SMA: | 51.6 | Buy |
| 8-day EMA: | 34.82 | Buy |
| 20-day EMA: | 18.1 | Buy |
| 50-day EMA: | 8.11 | Buy |
| 200-day EMA: | 2.15 | Buy |
KRYS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 241.57 | Buy |
| 20-day SMA: | 230.66 | Buy |
| 50-day SMA: | 209.99 | Buy |
| 200-day SMA: | 168.08 | Buy |
| 8-day EMA: | 240.02 | Buy |
| 20-day EMA: | 231.1 | Buy |
| 50-day EMA: | 212.45 | Buy |
| 200-day EMA: | 178.97 | Buy |
State Street Financial Sel Sec SPDR ETF Earnings Growth & XLF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Krystal Biotech, Inc. Earnings Growth & KRYS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.37 per share, and an increase next year of $1.76 per share.
State Street Financial Sel Sec SPDR ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Krystal Biotech, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||